China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
China Pharma Holdings Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
China Pharma Holdings Inc 的收入按细分市场或地理位置如何划分?
China Pharma Holdings Inc 주요 수익원은 Pharmaceutical Products이며, 최신 수익 발표에서 수익은 4,144,268입니다. 지역별로는 China이 China Pharma Holdings Inc의 주요 시장이며, 수익은 4,144,268입니다.